Research Article


Open Access
Tumor-intrinsic response to IFNγ shapes the tumor microenvironment and anti–PD-1 response in NSCLC
View ORCID ProfileBonnie L Bullock, View ORCID ProfileAbigail K Kimball, Joanna M Poczobutt, Alexander J Neuwelt, View ORCID ProfileHoward Y Li, Amber M Johnson, Jeff W Kwak, View ORCID ProfileEmily K Kleczko, View ORCID ProfileRachael E Kaspar, Emily K Wagner, Katharina Hopp, View ORCID ProfileErin L Schenk, Mary CM Weiser-Evans, View ORCID ProfileEric T Clambey, View ORCID ProfileRaphael A Nemenoff Correspondence email
Bonnie L Bullock
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Abigail K Kimball
2Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Joanna M Poczobutt
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Alexander J Neuwelt
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Howard Y Li
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
3Veterans Affairs Medical Center, Denver, CO, USA
Amber M Johnson
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Jeff W Kwak
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Emily K Kleczko
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Rachael E Kaspar
2Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Emily K Wagner
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Katharina Hopp
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Erin L Schenk
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Mary CM Weiser-Evans
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Eric T Clambey
2Department of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Raphael A Nemenoff
1Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Published 27 May 2019. DOI: 10.26508/lsa.201900328
SOCS1 regulates immunotherapy in NSCLC
Bonnie L Bullock, Abigail K Kimball, Joanna M Poczobutt, Alexander J Neuwelt, Howard Y Li, Amber M Johnson, Jeff W Kwak, Emily K Kleczko, Rachael E Kaspar, Emily K Wagner, Katharina Hopp, Erin L Schenk, Mary CM Weiser-Evans, Eric T Clambey, Raphael A Nemenoff
Life Science Alliance May 2019, 2 (3) e201900328; DOI: 10.26508/lsa.201900328
SOCS1 regulates immunotherapy in NSCLC
Bonnie L Bullock, Abigail K Kimball, Joanna M Poczobutt, Alexander J Neuwelt, Howard Y Li, Amber M Johnson, Jeff W Kwak, Emily K Kleczko, Rachael E Kaspar, Emily K Wagner, Katharina Hopp, Erin L Schenk, Mary CM Weiser-Evans, Eric T Clambey, Raphael A Nemenoff
Life Science Alliance May 2019, 2 (3) e201900328; DOI: 10.26508/lsa.201900328
In this Issue
Volume 2, No. 3
June 2019
Advertisement
Jump to section
Subjects
Related Articles
- No related articles found.
Cited By...
- Characterization of neoantigen-specific T cells in cancer resistant to immune checkpoint therapies
- Overcoming resistance to STING agonist therapy to incite durable protective antitumor immunity
- The FOXC2 Transcription Factor Promotes Melanoma Outgrowth and Regulates Expression of Genes Associated With Drug Resistance and Interferon Responsiveness